Expression, purification and crystallization ofHelicobacter pyloriL-asparaginase
- 31 July 2008
- journal article
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section F Structural Biology and Crystallization Communications
- Vol. 64 (8) , 740-742
Abstract
The L-asparaginases from Escherichia coli and Erwinia chrysanthemi are effective drugs that have been used in the treatment of acute childhood lymphoblastic leukaemia for over 30 years. However, despite their therapeutic potential, they can cause serious side effects as a consequence of their intrinsic glutaminase activity, which leads to L-glutamine depletion in the blood. Consequently, new asparaginases with low glutaminase activity, fewer side effects and high activity towards L-asparagine are highly desirable as better alternatives in cancer therapy. L-Asparaginase from Helicobacter pylori was overexpressed in E. coli and purified for structural studies. The enzyme was crystallized at pH 7.0 in the presence of 16-19%(w/v) PEG 4000 and 0.1 M magnesium formate. Data were collected to 1.6 A resolution at 100 K from a single crystal at a synchrotron-radiation source. The crystals belong to space group I222, with unit-cell parameters a = 63.6, b = 94.9, c = 100.2 A and one molecule of L-asparaginase in the asymmetric unit. Elucidation of the crystal structure will provide insight into the active site of the enzyme and a better understanding of the structure-activity relationship in L-asparaginases.Keywords
This publication has 21 references indexed in Scilit:
- Crystal Structure and Allosteric Regulation of the Cytoplasmic Escherichia coli l-Asparaginase IJournal of Molecular Biology, 2007
- Treatment of Acute Lymphoblastic LeukaemiaDrugs, 2007
- L-Asparaginase: A Promising Chemotherapeutic AgentCritical Reviews in Biotechnology, 2007
- Asparagine Synthetase ChemotherapyAnnual Review of Biochemistry, 2006
- Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia2006
- New Insights on AsparaginaseJournal of Pediatric Hematology/Oncology, 2005
- Upregulation of asparagine synthetase and cell cycle arrest in t(12;21)-positive ALLLeukemia, 2004
- Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer---Children's Leukemia Group phase 3 trialBlood, 2002
- Glutaminase‐free asparaginase from vibrio succinogenes: An antilymphoma enzyme lacking hepatotoxicityInternational Journal of Cancer, 1982
- Solvent content of protein crystalsJournal of Molecular Biology, 1968